Skip to main content

Table 3 Associations of SUA concentrations with NAFLD prevalence

From: Joint associations of serum uric acid and ALT with NAFLD in elderly men and women: a Chinese cross-sectional study

SUA levels Cases/n (%) Model 1 Model 2
OR 95% CI P OR 95% CI P
Total (n = 7569)
Q1 176/1523 (11.6) 1    1   
Q2 338/1536 (22.0) 2.41 1.97–2.95 < 0.001 1.78 1.41–2.23 < 0.001
Q3 473/1521 (31.1) 4.39 3.61–5.34 < 0.001 2.85 2.27–3.58 < 0.001
Q4 540/1481 (36.5) 6.31 5.16–7.72 < 0.001 3.19 2.52–4.04 < 0.001
Q5 702/15,084 (6.6) 10.92 8.88–13.44 < 0.001 4.34 3.39–5.54 < 0.001
Men (n = 3126)
Q1 98/603 (16.3) 1    1   
Q2 147/646 (22.8) 1.48 1.11–1.97 0.008 1.20 1.01–1.84 0.281
Q3 197/617 (31.9) 2.38 1.80–3.14 < 0.001 1.57 1.14–2.17 0.006
Q4 221/629 (35.1) 2.93 2.22–3.86 < 0.001 1.94 1.41–2.67 < 0.001
Q5 304/631 (48.2) 5.26 4.01–6.90 < 0.001 2.74 2.00–3.76 < 0.001
Women (n = 4443)
Q1 82/873 (9.4) 1    1   
Q2 152/881 (17.3) 2.04 1.53–2.71 < 0.001 1.70 1.24–2.34 0.001
Q3 226/910 (24.8) 3.27 2.48–4.29 < 0.001 2.27 1.67–3.08 < 0.001
Q4 355/878 (40.4) 6.83 5.23–8.91 < 0.001 4.07 3.02–5.48 < 0.001
Q5 447/901 (49.6) 10.19 7.80–13.31 < 0.001 4.60 3.39–6.24 < 0.001
  1. Category of SUA quintiles
  2. For all participants: Q1, < 231 μmol/L; Q2, 231–271 μmol/L; Q3, 272–312 μmol/L; Q4, 313–366 μmol/L; Q5, ≥ 367 μmol/L
  3. For men: Q1, < 278 μmol/L; Q2, 278–317 μmol/L; Q3, 318–355 μmol/L; Q4, 356–402 μmol/L; Q5, ≥ 403 μmol/L
  4. For women: Q1, < 213 μmol/L; Q2, 213–244 μmol/L; Q3, 245–276 μmol/L; Q4, 277–320 μmol/L; Q5, ≥ 321 μmol/L
  5. Model 1: adjusted for age and sex (only for all participants)
  6. Model 2: adjusted for age, sex (only for all participants), BMI, history of cardiovascular related diseases, DBP, serum AST, TG, TC, HDL and FPG